Swiss Pharma Nigeria Limited (Swipha) is a subsidiary of Servier, a French Pharmaceutical Company that employs over 20,000 employees with nearly 3,000 focusing on Research and Development.
Servier acquired Swipha in 2017 to launch the presence of the French second biggest pharmaceutical company and extend their wide range of products to Nigerians.
Our origin is from a Swiss corporation (Roche Pharmaceutical) which was incorporated in 1976. In 2008 became the first pharmaceutical company in Nigeria to obtain ISO 9001 certification and in 2014 again became the first company in West Africa to obtain WHO GMP certification.
We have our manufacturing site in the heart of Lagos producing over 50 SKUs, and over 30 brands across different therapeutic categories such as Anti-diabetes, Anti-infectives, Anti-malarial, Central Nervous System and Cardio-vascular.